Trial intelligence / Profile preview

Sertraline for intractable breathlessness

ACTRN12610000464066Phase 3Completed

Sponsor
Flinders University
Start
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial comparing Sertraline with Placebo (2 arms). Primary endpoint: Change in current sensation of breathlessness. Started Jan 2011; status: completed.

02

Drugs

sertraline

Beyond the preview

Go deeper on ACTRN12610000464066.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12610000464066.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call